Search - tctmd.com

Displaying 1 - 20 of 29

Sort: Relevancy | Date

News Daily News

FINEARTS-HF Analysis Supports Finerenone’s Value in HFpEF With Obesity

L.A. McKeown

December 13, 2024

News Daily News

Rethinking the Evidence for ICDs for HFrEF in Light of Today’s GDMT

L.A. McKeown

December 05, 2024

News Opinion CV Team Dispatch

November 2024 Dispatch for the CV Team

L.A. McKeown

November 26, 2024

News Conference News AHA 2024

Spironolactone No Help for the Heart After Acute MI: CLEAR SYNERGY

Shelley Wood

November 17, 2024

SUMMIT: Tirzepatide ‘Huge Win’ for HFpEF Patients With Obesity

News Conference News AHA 2024

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

Michael O'Riordan

November 16, 2024

News Conference News HFSA 2024

Biomarker and Echo Data Bolster Vutrisiran’s Promise in ATTR-CM

L.A. McKeown

October 04, 2024

News Conference News HFSA 2024

‘Metabolic Accelerator’ Cuts Weight, Not Muscle in HFpEF: HuMAIN-HF

Michael O'Riordan

October 03, 2024

News Conference News HFSA 2024

‘Global Efficacy’ of Aficamten for Obstructive Disease Shown in SEQUOIA-HCM

L.A. McKeown

October 02, 2024

News Conference News HFSA 2024

FINEARTS-HF: New Analyses Ask, Who Benefits Most From Finerenone?

Michael O'Riordan

October 02, 2024

News Conference News ESC 2024

FINEARTS-HF: Benefit of Finerenone Extends to HFmrEF and HFpEF Patients

Michael O'Riordan

September 01, 2024

News Conference News ESC 2024

Tri.Fr Trial Affirms Quality-of-Life Impact of Tricuspid TEER

Todd Neale

August 31, 2024

News Daily News

FDA Approves Dropping Aspirin for HeartMate 3 LVAD Patients

L.A. McKeown

August 21, 2024

News Daily News

Scoring System Puts Focus on Medical Therapy Optimization in HFrEF

L.A. McKeown

August 13, 2024

News Daily News

Acute HF Patients Live Longer When Seen by Specialists

Michael O'Riordan

August 09, 2024

News Daily News

ACC/AHA Update Performance, Quality Measures for HF Care

Todd Neale

August 08, 2024

News Daily News

FINEARTS-HF: Topline Results Support Role for Finerenone in Mildly Reduced or Preserved EF

L.A. McKeown

August 05, 2024

News Daily News

Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF

Michael O'Riordan

July 26, 2024

News Daily News

Semaglutide Has Similar Benefits in Women and Men With HFpEF

Todd Neale

June 26, 2024

News Daily News

Long-term Digoxin Use Linked to VT/VF Risk in HF Patients

L.A. McKeown

June 11, 2024

News Daily News

Kidney Events High in Older Patients After HF Hospitalization

L.A. McKeown

May 30, 2024

Advertisement

FINEARTS-HF Analysis Supports Finerenone’s Value in HFpEF With Obesity

Rethinking the Evidence for ICDs for HFrEF in Light of Today’s GDMT

November 2024 Dispatch for the CV Team

Spironolactone No Help for the Heart After Acute MI: CLEAR SYNERGY

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

Biomarker and Echo Data Bolster Vutrisiran’s Promise in ATTR-CM

‘Metabolic Accelerator’ Cuts Weight, Not Muscle in HFpEF: HuMAIN-HF

‘Global Efficacy’ of Aficamten for Obstructive Disease Shown in SEQUOIA-HCM

FINEARTS-HF: New Analyses Ask, Who Benefits Most From Finerenone?

FINEARTS-HF: Benefit of Finerenone Extends to HFmrEF and HFpEF Patients

Tri.Fr Trial Affirms Quality-of-Life Impact of Tricuspid TEER

FDA Approves Dropping Aspirin for HeartMate 3 LVAD Patients

Scoring System Puts Focus on Medical Therapy Optimization in HFrEF

Acute HF Patients Live Longer When Seen by Specialists

ACC/AHA Update Performance, Quality Measures for HF Care

FINEARTS-HF: Topline Results Support Role for Finerenone in Mildly Reduced or Preserved EF

Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF

Semaglutide Has Similar Benefits in Women and Men With HFpEF

Long-term Digoxin Use Linked to VT/VF Risk in HF Patients

Kidney Events High in Older Patients After HF Hospitalization

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content